Running title : Modulation of supraspinal fatigue
Introduction
Paragraph 1 Prolonged exercise or sustained contraction of a muscle group at low intensity induces a failure of the nervous system to activate the muscle at its maximal capacity (18, 36, 37) . The magnitude of voluntary activation is commonly estimated by inducing a supramaximal electrical stimulus to the motor nerve during an isometric maximal voluntary contraction (MVC; 40) . When extra force is evoked by the 'superimposed' stimulus, voluntary activation is considered as submaximal. A progressive deficit in voluntary activation usually develops during a prolonged exercise or contraction and is classically called central fatigue (9, 40) . Furthermore, studies applying transcranial magnetic stimulation (TMS) to motor cortical areas during an MVC suggested that, when the stimulation evokes an additional torque increment, part of the central fatigue can be due to an insufficient output from the motor cortex (9, 17, 36, 37, 38, 40) . This deficit is usually called supraspinal or cortical fatigue.
Paragraph 2 Although the underlying mechanisms are not yet understood, it has been
suggested that central fatigue might be related to a change in the synthesis and metabolism of brain monoamines, such as serotonin, dopamine and noradrenaline (for review; see 35) . These neurotransmitters play a key role in the modulation of various brain functions such as motivation, arousal, attention, stress responses, and motor control (2) . For example, it has been suggested from animal studies that an increased serotonergic activity (29) and the ratio of serotonin to dopamine brain content during exercise (6) may be important for the development of central fatigue. However, several pharmacological studies performed in humans failed to alter the exercise capacity through changes in serotonergic neurotransmission (32) , suggesting that the role of serotonin is often overestimated and dependent on drug dosages and receptor that is targeted (25) . Other investigations reported that pharmacologically induced inhibition of the reuptake of dopamine and noradrenaline led 6 to changes in performance in both normal (12, 33) and high ambient temperatures (30, 33, 34) . However, to our knowledge, no studies have investigated whether the effects of these drugs on the performance of a prolonged exercise are related to changes occurring at central/supraspinal level.
Paragraph 3
In humans, it is impossible to directly measure the effects of specific brain neurotransmitters on motor cortical excitability and output. Therefore, we pharmacologically manipulated the concentration of dopamine and noradrenaline to investigate the potential effects of these two brain neurotransmitters on central/supraspinal fatigue. Depending on the reseach field, supraspinal fatigue (38, 40) , sometimes called brain or cortical fatigue (22) , has been reported as an alteration affecting not only the motor cortex (38, 40) but also a frontoparietal network involved in cognitive functions (22) . These two aspects of fatigue can be investigated by measuring voluntary activation (9, 17, 38, 40) and assessing cognitive performance (22, 24) in the same experiment. Accordingly, electrophysiogical methods (voluntary activation tested by TMS) and a vigilance task (Psychomotor Vigilance Task or PVT; 22) were used to explore further the supraspinal component of central fatigue shortly after a prolonged cycling exercise performed in temperate environment. We hypothesized that if there is a supraspinal component in central fatigue, the effects would affect not only the motor output, but also the cognitive function.
Material and methods

Subjects
Paragraph 4 Ten well trained cyclists or triathletes (age 27 ± 6 yr; height 1.81 ± 0.05 m; mass 75.7 ± 8.0 kg; maximal power output (Wmax) 367 ± 23W; VO 2 max 67 ± 7 ml/min/kg) participated in this investigation. In the present study, a fatiguing exercise involving most of the lower limb muscles was preferred to an isometric contraction of an isolated muscle group as it induces a much longer depression in voluntary activation (27, 36) . The time trial protocol applied (see description below) has been shown to be much more reliable and reproducible than a constant load exercise sustained to exhaustion, especially in well-trained subjects (14) . Therefore, the subjects selected for this experiment had an experience of at least five years of regular cycling training and competition that ensured a high degree of reproducibility of performance across the different trials (14, 32, 33, 34) . Because of potential issues with the menstrual cycle and hormonal variations in female subjects, experiments were only performed on a male population.
Paragraph 5
Before the beginning of the study, all volunteers received written information regarding the nature and purpose of the experimental protocol. Following an opportunity to ask questions, a written statement of consent was signed. The experimental protocol was approved by the Ethics Committee of the Vrije Universiteit Brussel (Brussels, Belgium) and experiments were performed in accordance with the Declaration of Helsinki.
Cycling exercise
Paragraph 6
Prior to the experimental sessions, all subjects completed a maximal exercise test which consisted of a continuous incremental cycling exercise. Subjects started the maximal exercise test at a resistance of 80W, every three minutes 40W was added until volitional exhaustion, i.e. the moment that subjects could not maintain 80 RPM. This test was used to determine the power output required to elicit 55% and 75% Wmax and VO 2 max. The experimental cycling protocol was identical to the one used previously (33, 34) . Subjects completed a familiarization trial, followed by three experimental trials, all separated by at least 5 days to ensure full recovery. The first part of each trial consisted of 60 min fixed intensity exercise at a workload corresponding to 55% Wmax, and was followed by a time trial (TT) to measure performance. There was a 1-2 min delay between the end of the 8 constant load exercise and the beginning of the TT, to program the ergometer (Lode Excalibur Sport, Groningen, the Netherlands). The TT required the subjects to complete a predetermined amount of work equal to 30 min at 75% Wmax as quickly as possible (14) .
Subjects began the TT at a workload corresponding to 75% Wmax, but were free to increase or decrease their power output as desired from the outset. During the TT, a computer program displayed a bar indicating the percentage of total work completed to give the subject an indication of his progress. Throughout the protocol, no feedback was provided regarding time lapsed, power output, pedal cadence or heart rate. During exercise subjects had ad libitum access to plain water. Ratings of perceived exertion (RPE; scale from 6 to 20; 4), and heart rate were assessed during the TT. Core temperature was measured before and during the cycling exercise.
Drugs
Paragraph 7
Subjects were randomly assigned to one of three drug treatments. The first treatment consisted of 8 mg reboxetine (Rebox; noradrenaline reuptake inhibitor) on the night before the experiment. On arrival in the lab, subjects ingested another 8 mg Rebox. In the second condition, subjects ingested a placebo (lactose; 20 mg) on the night before the experiment and 40 mg of methylphenidate (Mph; dopamine reuptake inhibitor) on arrival in the lab. Mph is an amphetamine-like stimulant that is widely administered to treat children with attention deficit hyperactivity disorder (31) . It is currently on the doping list of the World Anti-Doping Agency (WADA), indicating athletes can only use it under the condition of therapeutic use exemption. The third treatment was the placebo (Pla), both the night before and the day of the experimental trial subjects ingested 20 mg lactose. The treatment was randomized and administered in a double-blind cross-over manner. Rebox, Mph and Pla 9 capsules were prepared by an independent pharmacy to appear indistinguishable with regard to dimensions and color.
Ergometric device
Paragraph 8
The neuromuscular parameters were recorded while the subjects sat on an adjustable chair such that the hip and knee joints were at 100° (angle between trunk and thigh) and 80° (full extension = 0°), respectively. The chair had a long back-rest to provide full back support. The head of the subjects was secured in a custom-made headrest to ensure a stable position during the experiment. The right leg of the subjects was connected to a force transducer placed ~2 cm above the lateral malleolus using velcro straps. To minimize the movement of the trunk during contractions, the subject was attached to the chair by a racing harness. The position of the headrest and force transducer as well as the harness adjustments were recorded for each subject to ensure identical position in each experimental session.
Torque and electromyographic recordings
Paragraph 9
The isometric torque developed by the knee extensor muscles was measured by a force transducer (linear range, 0-2,500 N; U2000 load cell, Maywood Instruments Ltd, Basingstoke, UK) connected to the leg and the chair by a rigid system. The signal from the force transducer was amplified by a custom-made amplifier. Voluntary and electrically evoked electromyographic (EMG) activities were recorded from the rectus femoris, the vastus medialis and the long head of the biceps femoris by means of selfadhesive bipolar electrodes (Ag-AgCl, 10-mm diameter, interelectrode distance 5 cm). The EMG electrodes were placed over the muscle belly of each muscle; ~10 cm proximal to the superior border of the patella for the rectus femoris and on the mid-part of the muscle belly, determined by manual testing, for the vastus medialis and the long head of the biceps femoris.
10
The ground electrodes were located over the lateral condyle of the tibia. The position of the electrodes was marked with indelible ink to ensure a similar location on the different visits.
All EMG signals were amplified ( 1,000) and filtered (10 Hz to 1 kHz) by a custom-made differential amplifier. The EMG and torque signals were acquired on a personal computer at a sampling rate of 2 kHz with a data-acquisition system and analyzed off-line with AcqKnowledge analysis software (Model MP 100, Biopac Systems, Santa Barbara, CA, USA).
Paragraph 10
The potential effect of EMG crosstalk between knee extensor muscles and biceps femoris was evaluated in four subjects by recording the EMG activity of biceps femoris, vastus medialis and rectus femoris muscles during a maximal electrical stimulation of the latter one at its motor point. To quantify crosstalk, the ratio between the amplitude of the signal recorded over biceps femoris or vastus medialis and the stimulated muscle was then computed. The EMG amplitude of the biceps femoris and vastus medialis were respectively ≤ 4 and 6% of the rectus femoris amplitude indicating that cross-talk between synergist and antagonist muscles was negligible in our experimental conditions.
Electrical stimulation
Paragraph 11
The knee extensors were stimulated by single supramaximal electrical pulses (0.2-ms duration) delivered by a constant current stimulator (DS7A Digitimer, Welwyn Garden City, UK) that was triggered by a digital timer (Master-8, AMPI, Jerusalem, Israel).
The stimuli were delivered to the femoral nerve through two self-adhesive electrodes (AgAgCl, 10-mm diameter). The cathode was positioned over the nerve in the femoral triangle, and the anode was placed midway between the greater trochanter and the iliac crest (36) . The precise location of the cathode was determined at rest by weak electrical stimulation whereas the maximal stimulus intensity was adjusted during submaximal contractions (~50% MVC). The level of stimulation was then set 30% above that required to induce a Mmax during the submaximal contractions. 
Transcranial magnetic stimulation
Psychomotor Vigilance Task
Paragraph 13
The psychomotor vigilance test was used as a sustained attention task in present study (22) . For a detailed description of the task, readers are referred to the original study by Dinges and Powell (8) . Briefly, a laptop computer displayed a visual stimulus (fireball, always in the middle of the screen) at a variable interval (between 2-10 s). Subjects were required to respond by pressing the space-bar with the index of the dominant hand. The distance between the subject's eyes and the screen was ~40 cm. Subject's reaction time was displayed on a computer screen for 1s after space-bar pressing. If the subject did not respond within 500 ms, the trial was stored as a lapse, and a warning message appeared to the participant.
Paragraph 14
The PVT was performed once before and once 15 min after the end of the cycling exercise when the subject was sitting on the chair used for the recording of the neuromuscular parameters (see description above). The PVT ran for a total period of 10 min (100 stimuli). The reaction time of correct responses (<500 ms) and number of lapses were stored.
Experimental protocol
Paragraph 15
As already mentioned, all subjects participated in a familiarization session and three experimental sessions (Pla, Rebox and Mph). The familiarization trial was undertaken to ensure that subjects were accustomed to the procedures employed during the investigation and to minimize any potential learning or anxiety effects. During this session, the subjects practiced the isometric contractions and experienced the electrical motor nerve stimulation and TMS. The familiarization trial was identical to the experimental trials in all respects.
Paragraph 16
Experimental trials were undertaken in temperate (18 o C) conditions with relative humidity maintained between 50-60%. Subjects were instructed to record dietary intake and physical activity during the two days before the first trial, and to replicate this in the two days prior to the subsequent experimental trials. No exercise, caffeine or alcohol consumption was permitted in the 24 hours before each trial. For each subject the four sessions were performed at the same time of the day, either at the end of the morning or in the afternoon. For all trials, subjects were dressed in cycling shorts, socks and shoes.
Paragraph 17
On arrival in the lab, subjects inserted a rectal thermister (Gram Corporation LT-8A, Saitama, Japan) 10 cm beyond their anal sphincter for the measurement 13 of core temperature and heart rate was recorded telemetrically by a cardio frequency meter (Polar Accurex plus, Kempele, Finland). They were then placed in the experimental chair to record the neuromuscular parameters. After a warm up period consisting in a few submaximal contractions, subjects performed 2-3 brief MVCs (~2-3 s) to determine their baseline maximal torque. The torque of the greatest MVC was then measured, and two submaximal target torques (50 and 75% MVC) were determined and displayed on a computer screen used as visual feedback. Thereafter, pre-exercise recordings were started. Voluntary activation was tested by TMS and motor nerve stimulation. To that end, subjects performed sets of brief contractions. Each set was composed of a brief MVC followed by contractions at 50% and 75% MVC, and ended by an MVC. TMS was delivered during the first three contractions whereas motor nerve stimulation was delivered during the last MVC. Subjects were asked to maintain the required contraction level during and immediately after TMS or motor nerve stimulation. The resting potentiated twitch was recorded in response to motor nerve stimuli delivered 3-5 s after the last MVC (Figure 1 ). The order of the contractions at the different intensities (50, 75% and 100% MVC) and of the two stimulation types (TMS and electrical stimulation) was randomized across subjects but was kept constant for each subject across experimental sessions. For the pre-exercise recordings, three sets of contractions were at least performed ( Figure 1) . In each set, the contractions were separated by 10 s rest, and sets were separated from each other by 4 min rest. The TMS protocol, originally introduced by Todd and colleagues (40) , has been shown to produce reliable estimations of resting twitch and voluntary activation in the knee extensor muscles (11, 36) .
[ 
Data analysis
Paragraph 19
The duration of the TT and the time course of the power output during the TT were measured. For the trial that produced the greatest MVC torque, the maximum torque and associated average EMG activity (aEMG) of rectus femoris, vastus medialis and biceps femoris, recorded before and after the cycling exercise, were determined for a 500-ms period during the MVC torque plateau. The peak-to-peak amplitude and area of the MEP, and the Mmax recorded during the contractions at different intensities were also measured. As 100 (36, 40) . For the PVT, reaction time and lapses averages before and 15 min after the cycling exercise were compared for each subject.
Statistical Analysis
Paragraph 20 Prior to comparing each dependent variable, the normality of the data was confirmed with the Kolmogorov-Smirnov test. To evaluate differences in time necessary to complete the TT and in mean power output during the TT in the three conditions (Rebox, Mph and Pla), a one-way ANOVA with repeated measures was used. Data collected over time before, during and after the cycling exercise were analyzed using a two-factor (drug x time)
ANOVA with repeated measures. When a significant main effect was found, a Tukey post hoc test was used to identify the significant differences among the selected means. The relation between subjects' change in MVC torque and voluntary activation tested by TMS 10 min after the TT was fitted by a linear regression using the least-squares method. For all comparisons, statistical significance was accepted at P<0.05. Data are reported as means ± SD within the text, and means ± SEM in the figures.
Results
TT performance
Paragraph 21 All subjects completed the three experimental trials. 
MVC torque and aEMG
Paragraph 23
Before the cycling exercise, average MVC torque was similar (P=0.87)
for Pla, Rebox and Mph trials and corresponded to 233.3 ± 65.5, 236.0 ± 73.3 and 232.8 ± 67.4 Nm, respectively. When recorded 10 min after the end of the TT, the MVC torque was significantly reduced for the three conditions (post hoc tests: P<0.05; Figure 2B ). This reduction tended to be slightly greater for Rebox as compared to Pla and Mph trials (P=0.15; Figure 2B ). For the three conditions, the deficit in MVC torque was still present after 45 min of recovery (post hoc tests: P<0.05).
Paragraph 24
As for the MVC torque, the corresponding aEMG for the agonist and antagonist muscles were also similar in pre-exercise conditions regardless of the drug administrated (P>0.37 P=0.56).
Paragraph 26
The MEP latency and SP duration, measured in rectus femoris and vastus medialis, were similar during pre-exercise recordings for the three conditions (P>0. 8) and did not change after the cycling exercise (ANOVA time effect: P>0.25; Table 1 ).
Regardless the drug administrated, the Mmax area recorded during the MVC was not statistically different before exercise for rectus femoris (P=0.32) and vastus medialis (P=0.11), and unchanged when measured 10 min after the cycling exercise compared with control values (ANOVA time effect, P=0.53 and P=0.49, respectively; Table 1 ).
[ Figure 3C ). There was a significant ANOVA interaction between drug and time (P<0.05) and post-hoc tests indicated that voluntary activation was significantly reduced in the Rebox condition (5.4%; P<0.001) but unchanged for Pla and Mph conditions (P=0.7 and P=0.9, respectively) when measured 10 min after the end of the cycling exercise ( Figure 3C ). For the
Rebox trial, this reduction persisted till 45 min of recovery (P=0.2).
Paragraph 28 A significant linear association (y = 0.83x + 16.56; r²= 0.29) between subjects' voluntary activation tested by TMS and change in MVC torque 10 min after the end of the TT was found when data from the three conditions were plotted together (P<0.01).
[ and 94.6 ± 5.0%, respectively; Figure 3D ). For the three conditions, it was slightly reduced 10 min after the end of the cycling exercise but again, the difference was only statistically significant for the Rebox condition (4.7%, P<0.05; Figure 3D ). Although still present after 30 min of recovery, the deficit in voluntary activation was no more statistically different (P=0.07) from control value.
Twitch contractile properties
Paragraph 30
The peak torque of the twitch induced by motor nerve stimulation at rest did not differ statistically between the three conditions during pre-exercise recordings (P=0.11; Table 2 ). Compared with control values, it was significantly decreased shortly after the TT in the three conditions (post hoc tests: P<0.05; Table 2 ). There was, however, no significant ANOVA interaction between drug and time (P=0.4). Twitch torque was still significantly lower than control values after 45 min of recovery (post hoc tests: P<0.05). As for peak torque, the twitch time-to-peak torque and half-relaxation time were similar for the three conditions during pre-exercise recordings (P=0.18 and 0.73, respectively; Table 2 ). Ten min after the end of the TT, all these values were reduced for Pla, Rebox and Mph (post hoc tests: P<0.05; Table 2 ). The twitch time-to-peak torque recovered during the following resting period and did not differ statistically from control value after 30 min of recovery for Mph (P=0.21) and after 45 min for Pla (P=0.07) and Rebox (P=0.63). Half-relaxation remained below the initial values at the end of the recovery period for Pla (P<0.01) and Mph (P<0.05)
but not for Rebox (P=0.27).
PVT
Paragraph 32
The control values for the reaction time and number of lapses were similar regardless of the drug administrated (P=0.73 and 0.40 for the reaction time and number of lapses, respectively; Table 3 ). For the reaction time, the ANOVA showed a significant interaction between drug and time (P<0.05). It increased significantly for the Rebox condition (P<0.01), did not change for the Pla trial (P=0.97) and decreased for the Mph trial (P<0.01; Table 3 ). In contrast, the number of lapses did not change significantly after the cycling exercise for any condition (ANOVA time effect: P=0.48; Table 3 ).
[ Table 3 ]
Discussion
Paragraph 33
The objective of the current study was to investigate the potential link between neural fatigue and changes in brain concentration of noradrenaline and dopamine by combining neurophysiogical methods and pharmacological manipulation of these two neurotransmitters in a temperate environment.
To that purpose, we tested the effects of oral administration of noradrenaline and dopamine reuptake inhibitors on acute cycling 21 performance and central/supraspinal fatigue. The main novel finding is that the decrease in cycling performance induced by the noradrenaline reuptake inhibition was accompanied by a greater central/supraspinal fatigue, and a worsened PVT performance. In contrast, the dopamine reuptake inhibition did not influence the TT performance and central/supraspinal fatigue differently than the placebo in the current environmental conditions.
TT performance, MVC torque and twitch contractile properties
Paragraph 34 TT performance was decreased in Rebox condition whereas Mph had no significant influence on performance. These results are in agreement with previous studies performed in our laboratory during similar cycling exercise and environmental conditions (33, 34) . Whereas the TT performance was not influenced by Mph in normal ambient temperature (18°C), it was improved by 16% in the heat (30°C; 34). The lack of effect of Mph in temperate conditions was confirmed, even though the dose of Mph has been doubled (40 vs.
20 mg) compared with our previous investigation (34).
Paragraph 35
The decline in MVC torque measured 10 min after the end of the TT
was lower than what is usually reported for moderately trained subjects after similar cycling efforts (18, 36) but comparable to well-trained cyclists or triathletes (20, 28) . The mean decrease in MVC torque was slightly greater for Rebox than Pla trial. However, this difference did not reach statistical significance. This observation may be partly explained by the modest fatigue-related decline in MVC torque in the three conditions and the relatively high inter-subject variability. However, when individual data of the three conditions were plotted together, a significant linear association (r² =0.29; P<0.01) was observed between subjects' voluntary activation tested by TMS 10 min after the TT and changes in MVC torque. This observation suggests that the level of voluntary activation measured shortly after the TT, and which is influenced by the drug administrated, contributed partly to reduce MVC torque.
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The relatively greater reduction in TT performance compared with the loss of MVC torque under Rebox condition could be due to the delay required (10 min) to replace very precisely the subject on the experimental setup used to test the electrophysiological parameters after the end of the cycling exercise. During such time period some recovery may have occurred.
Furthermore, the contribution of neural factors (see below) to the alteration in performance may be more pronounced for a multi-joints task such as cycling than for a single joint isometric MVC that requires less complex muscular synergy.
Paragraph 36
The decrease of the electrically-induced resting twitch and ERT observed in our study indicates that impairment of the excitation-contraction coupling contributes to the fatigue observed after prolonged cycling (18, 20, 36) . The similar decrease in twitch torque and time course for the three conditions suggests that peripheral fatigue induced by the cycling exercise was not worsened by the noradrenaline reuptake inhibitor.
Consequently, the negative influence of Rebox on TT performance should be mainly due to neural impairments. The shortened twitch time course (time-to-peak torque and halfrelaxation time) was most probably related to the increase in core temperature (5) and the relative interaction between fatigue and postactivation potentiation (10) . (27, 36) . Our results may however be explained by the high training level of our subjects as it has been reported that well-trained athletes did not display significant central fatigue when tested within a 30 min period after prolonged cycling exercise (20, 28) .
Neural contribution to muscle fatigue
Paragraph 38
In contrast to the Pla trial, a significant central fatigue was observed in the Rebox condition. Indeed, we observed a similar deficit in voluntary activation when tested 10 min after the TT by TMS and motor nerve stimulation. Although both TMS and motor nerve stimulation measure the failure of the nervous system to drive the muscle maximally during fatigue, TMS probes more specifically the supraspinal component of central fatigue (36, 38, 40) . A direct quantitative comparison of the two techniques is not straighforward because they can activate synergistic muscles differently and the shapes of the voluntary activation-force relations for motor cortical and motor nerve stimulation differ slightly (38, 40) , however, the reduction in voluntary activation tested by TMS indicates that a long-lasting 
Location of neural impairments and possible mechanisms
Paragraph 39 As the normalized MEP area recorded during the MVC did not change following the cycling exercise, the responsiveness of neurons in the pathway from the motor cortex to the muscle was presumably not impaired (21, 36) . Similarly, as the SP duration was not affected for the three conditions when tested shortly after the cycling exercise, a change in intracortical (13) or/and motor neuronal inhibition is unlikely (38) .
Paragraph 40
The PVT is considered as a reliable method to measure "cognitive fatigue", defined as "vigilance decrement," or "time on-task effect" (24) , consequent for example to sleep deprivation or during taxing cognitive tasks (22) . Our observation of a greater PVT performance after exercise in the Mph condition is consistent with studies
showing that this drug can improve performance in vigilance tasks in healthy subjects and patients with attention deficit disorder (31, 39) . In contrast, Rebox had a negative effect on PVT performance after exercise. The changes in reaction time observed after the end of TT in
Rebox and Mph conditions cannot be ascribed to a change in motor time because MEP latency and twitch time-to-peak torque displayed a similar time course in the three conditions.
Since Rebox in resting conditions has no significant effect on reaction time during psychometric tests in healthy subjects (16), it is suggested that the noradrenaline reuptake inhibitor and exercise interact at the supraspinal level and affect brain centers located prior to the motor cortex.
Paragraph 41
Animal studies have shown that the locus coeruleus, which contains the neurons synthesizing noradrenaline, provides numerous projections to different parts of the central nervous system involved in behavioral, attention, arousal and vigilance regulation (for a review; see 3). Recent works indicate that noradrenaline contributes to maintain forebrain neuronal activity states appropriate for sensory information integration (e.g. waking) and modulates the collection and processing of salient sensory information (3) through its projections to cortical and subcortical sensorimotor, attention, and memory circuits (3, 19) . In addition, iontophoretically applied noradrenaline in anesthetized animals can enhance both excitatory and inhibitory responses of somatosensory cortical neurons to afferent synaptic input (42) . This last effect was selective for noradrenaline since dopamine does not exhibit a similar property (41) .
Paragraph 42
The noradrenaline reuptake inhibitor we administrated may thus have affected the integration of sensory information or/and motor cortical sensitivity to these sensory afferents and consequently altered the generated motor output (1). This discussion is consistent with the observation that PVT activates a fronto-parietal network involved in attention, motivation, sensory information integration and motor programming (22) 
Paragraph 43
In conclusion, the alteration of the cycling performance due to the ingestion of a noradrenaline reuptake inhibitor was associated with a greater decrease in voluntary activation and PVT performance than in the Pla condition in well-trained male subjects. In contrast, dopamine reuptake inhibition had no additional effect than placebo in temperate conditions. These original findings suggest that noradrenaline, but not dopamine reuptake inhibition, contributes to the development of supraspinal fatigue observed after a prolonged cycling exercise performed in temperate environment. Because corticospinal excitability was not modified after the cycling exercise, noradrenaline appears to affect more specifically the supraspinal centers located prior to the motor cortex. As a consequence, the output from the motor cortex becomes insufficient to drive the muscles optimally and thereby likely contributes to affect motor performance. Table   Table 3 . PVT reaction time and number of lapses measured during pre-exercise recordings 2.8 ± 3.0
Data are means ± SD. *Significant difference between Control and R15 (P < 0.05). 
